Diamyd Medical Stock Forecast - Simple Regression
| DMN Stock | EUR 1.03 0.08 7.21% |
The Simple Regression forecasted value of Diamyd Medical AB on the next trading day is expected to be 0.87 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 2.89. Diamyd Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Diamyd Medical's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 6th of January 2026 The value of RSI of Diamyd Medical's share price is above 80 suggesting that the stock is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 92
Buy Peaked
Oversold | Overbought |
Using Diamyd Medical hype-based prediction, you can estimate the value of Diamyd Medical AB from the perspective of Diamyd Medical response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Diamyd Medical AB on the next trading day is expected to be 0.87 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 2.89. Diamyd Medical after-hype prediction price | EUR 1.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Diamyd |
Diamyd Medical Additional Predictive Modules
Most predictive techniques to examine Diamyd price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Diamyd using various technical indicators. When you analyze Diamyd charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Diamyd Medical Simple Regression Price Forecast For the 7th of January
Given 90 days horizon, the Simple Regression forecasted value of Diamyd Medical AB on the next trading day is expected to be 0.87 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 2.89.Please note that although there have been many attempts to predict Diamyd Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Diamyd Medical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Diamyd Medical Stock Forecast Pattern
| Backtest Diamyd Medical | Diamyd Medical Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Diamyd Medical stock data series using in forecasting. Note that when a statistical model is used to represent Diamyd Medical stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.5026 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0467 |
| MAPE | Mean absolute percentage error | 0.0514 |
| SAE | Sum of the absolute errors | 2.8925 |
Predictive Modules for Diamyd Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Diamyd Medical AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Diamyd Medical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Diamyd Medical stock to make a market-neutral strategy. Peer analysis of Diamyd Medical could also be used in its relative valuation, which is a method of valuing Diamyd Medical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Diamyd Medical Market Strength Events
Market strength indicators help investors to evaluate how Diamyd Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Diamyd Medical shares will generate the highest return on investment. By undertsting and applying Diamyd Medical stock market strength indicators, traders can identify Diamyd Medical AB entry and exit signals to maximize returns.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 1.03 | |||
| Day Typical Price | 1.03 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.08) | |||
| Relative Strength Index | 92.56 |
Diamyd Medical Risk Indicators
The analysis of Diamyd Medical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Diamyd Medical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting diamyd stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.71 | |||
| Semi Deviation | 2.79 | |||
| Standard Deviation | 4.04 | |||
| Variance | 16.35 | |||
| Downside Variance | 12.6 | |||
| Semi Variance | 7.79 | |||
| Expected Short fall | (4.18) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Other Information on Investing in Diamyd Stock
Diamyd Medical financial ratios help investors to determine whether Diamyd Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diamyd with respect to the benefits of owning Diamyd Medical security.